SavedAdd your journal

Journals / Pediatric Practice and Research / 2021 / Cilt: 9 - Sayı: 1

Çocuklarda COVID-19 ve Karaciğer

Anna Carina ERGANİ
Reyhan GÜMÜŞTEKİN
Meltem GÜMÜŞ
Halil Haldun EMİROĞLU
Pages
45–49
Publication Date
2021-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this purpose, COVID-19 has also published a special guide for those with chronic liver disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The coronavirus disease 2019 (COVID-19) epidemic caused by SARS-CoV-2 continues to be a major health and economic problem worldwide.
📊
Key Findings & Data:Different treatments are being studied for COVID-19, some of which have been linked to hepatotoxicity.
💡
Conclusion & Impact:For this purpose, COVID-19 has also published a special guide for those with chronic liver disease.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:SARS-CoV-2 · pediatrik COVID-19 · gastroenteroloji

Abstract

The coronavirus disease 2019 (COVID-19) epidemic caused by SARS-CoV-2 continues to be a major health and economic problem worldwide. There is not enough information about how the infection affects the liver in children and chronic liver disease is a risk factor for this infection. Different treatments are being studied for COVID-19, some of which have been linked to hepatotoxicity. Due to the increasing number of patients worldwide, new approaches have been developed to protect those with chronic liver disease from SARS-CoV-2 infection, considering that the risk of severe disease may increase. For this purpose, COVID-19 has also published a special guide for those with chronic liver disease.

Özet

SARS-CoV-2’nin neden olduğu koronavirüs hastalığı 2019 (COVID-19) salgını, dünya çapında önemli bir sağlık ve ekonomik sorun olmaya devam etmektedir. Çocuklarda enfeksiyonun karaciğeri nasıl etkilediğine ve kronik karaciğer hastalığının enfeksiyona yakalanma risk faktörü olmasına ilişkin bilgiler henüz yeterli düzeyde değildir. COVID-19 için farklı tedaviler incelenmektedir ve bunlardan bazıları hepatotoksisite ile ilişkilendirilmiştir. Dünya çapında artan hasta sayısı nedeniyle, ağır hastalık riski olasılığının artabileceği düşünülerek kronik karaciğer hastalığı olanları SARS-CoV-2 enfeksiyonundan korumak için yeni yaklaşımlar geliştirilmeye başlanmıştır. Bu amaçla kronik karaciğer hastalığı olanlar için COVID-19 özel bir rehberi de yayınlamıştır.

🔖

Cite This Article

ERGANİ, A. C., GÜMÜŞTEKİN, R., GÜMÜŞ, M., EMİROĞLU, H. H. (2021). Çocuklarda COVID-19 ve Karaciğer. Pediatric Practice and Research, Cilt: 9 - Sayı: 1, 45–49. https://ajindex.com/articles/795372

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Cevik M, Bamford C, Ho A. COVID-19 Pandemic-a focused review for clinicians. Clinical Microbiology and Infection. 2020 Apr 21
  2. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med. 2020;382:727–33
  3. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. The Journal of Heart and Lung Transplantation. 2020 4. Portincasa P., Krawczyk M., Antonia Machill, Lammert F., Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting?. Eur J Intern Med. 2020 Jul; 77: 18–24
  4. Zhang C., Shi L., Wang F.S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428–430
  5. Cai Q., Huang D., Yu H., Zhu Z., Xia Z., Su Y. Characteristics of liver tests in COVID-19 patients. J Hepatol. 2020 doi: 10.1016/j.jhep.2020.04.006
  6. Bangash M.N., Patel J., Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020 doi: 10.1016/S2468-1253(20)30084-4
  7. Ridruejo E., Soza A. The liver in times of COVID-19: What hepatologists should know. Ann Hepatol. 2020 July-August; 19(4): 353–358
  8. Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y. Characteristics of Liver Tests in COVID-19 Patients. J Hepatol. 2020 10.Schaefer E.A.K., Arvind A., Chung R.T. et al. Interrelationship Between Coronavirus Infection and Liver Disease. CLINICAL LIVER DISEASE, VOL 15, NO 5, MAY 2020
  9. Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology. 2020 12. Fan Z, Chen L, Li J, Cheng X, Jingmao Y, Tian C. Clinical Features of COVID-19-Related Liver Damage. Clin Gastroenterol Hepatol. 2020 13. Isabel Garrido I., Liberal R., Macedo G. COVID‐19 and liver disease—what we know on 1st May 2020. Aliment Pharmacol Ther. 2020 Jun 2: 10.1111/apt.15813
  10. Sultan S, Altayar O, Siddique SM, et al. AGA institute rapid review of the GI and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative medicine of patients with COVID-19. Gastroenterology. 2020 May; doi: 10.1053/j.gastro.2020.05.001
  11. Ludvigsson F. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088‐1095
  12. Qiu H, Wu J, Hong L, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID‐19) in Zh